Oncotarget Contributes to the Fight against Cancer for a Healthier Society

Introduction

Currently, scientific research provides the best means for battling diseases. With the historical evolution of science, there have been various opportunities for scientists, physicians, and policymakers to generate potent drugs and therapies for various diseases. Since time immemorial, diseases like cancer have been mysterious and challenging to treat in any way. Many people have lost lives battling cancer because most of the time, it is arrested at a late stage where treatment and control of the living growing cells are close to impossible. Read more about Oncotarget at Bioxbio.

Donation

That is why many donors and the world as a whole have been camping in research institutes, the internet and banks to contribute in the battle against cancer. One such individual to actively participate in battling cancer, by all means, is Mikhail Blagosklonny. Blagosklonny is the chief editor of Oncotarget, a preview scientific journal, readily available for sharing and disseminating data on cancer and various diseases and infections globally. The role of Oncotarget in the society has been to fight cancer globally through the use of qualified physicians who publish articles on the same.

Mission

With the universal drive towards an infection free society increasingly rising over the years, many governments and health sectors have gained momentum in adopting many research-based methodologies like Oncotarget to fight diseases. Being a top-notch peer-reviewed scientific journal for articles, it has embarked on a mission focused on providing answers towards the cure of illness. Following this mission, Oncotarget has increasingly registered massive gains through publishing researchers surrounding advanced and at times strange but helpful discoveries on cancer and various diseases. Read more: https://www.dovepress.com/oncotargets-and-therapy-journal

Contribution

A recent article in Oncotarget highlighted that although e-cigarettes have for a long period been considered healthy, they have negatively adverse effects to gum. E-cigarettes cause bleeding gums hence, not entirely safe for users. Oncotarget proceeded to publish the new subtype of cervical cancer. Additionally, the journal explained that cancer treatment drugs contributed to weight loss. Being an open and easy to access preview journal, Oncotarget is involved in determining key issues linked to the dissemination of cancer-related information with the aim of offering treatment. With its weekly publications, the journal is bound to reach masses in the society. It, therefore, means that Oncotarget plays a key role in battling cancer and other diseases.

Leave a Reply

Your email address will not be published. Required fields are marked *